Company Information

Company Sopharma Pharmaceuticals
www.sopharmagroup.com
Type:
Company
Country:
Bulgaria
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
11 March 2004
Next Communication on Progress (COP) due on:
31 July 2024

Financial Information


Communication On Progress

Published On Title Level/Status
2022-07-21 Communication on Progress Sopharma 2021 Advanced
26-Apr-2022 Grace Letter Not applicable
2021-04-20 Sopharma Communication on Progress 2020 Active
2019-07-19 Communication on Progress Sopharma 2018 ...and still growing Active
2018-03-21 Communication on Progress Sopharma 2017 Active
2017-03-17 Communication on Progress Advanced
2016-03-18 Communication on Progress Advanced
2015-03-18 Communication on Progress Active
2014-04-10 COP 2014 - Sopharma AD Active
2013-04-17 Communication on Progress 2013 Sopharma AD Learner
2012-04-19 2012 Communication on Progress Sopharma AD Active
2011-01-24 2011 Communication on Progress Not applicable
2007-07-10 Sopharma Pharmaceuticals Communication on Progress 2006 Not applicable
2007-07-10 Letter from CEO/Sopharma Pharmaceuticals Communication on Progress 2006 Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.